Rilpivirine (TMC278) matches efavirenz in phase 3 studies, with fewer side-effects
Hepatitis C epidemic in HIV-positive gay men in Netherlands seems to have levelled off
Incentives and phone follow-up could improve healthy behaviour by young people: more research needed
The future of AIDS activism: looking for sustained energy and new tactics 10 years after Durban
People with HIV/hepatitis C co-infection more likely to develop osteoporosis
Immigrants are more risk of HIV in their host country than back at home
Malawi plans 'test and treat' approach for pregnant women to cut mother-to-child HIV transmission
Protease inhibitor to raltegravir switch maintains viral suppression, but NRTI resistance lowers efficacy
Microbicides – where next?
Low birth weight seen in small minority of infants exposed to some antiretroviral drugs
Microbicides and circumcision could achieve modest cuts in HIV infections in Africa
High HIV incidence for Thai men who have sex with men; many acquiring HIV in their early twenties
Indirect evidence that treatment is bringing down HIV transmission in Denmark
Bill Gates maps the way to more effective HIV prevention
Tenofovir microbicide halves genital herpes infections and appears safe
